Publications by authors named "Dee Lin"

Claim this Profile
C
Cost per responder for teclistamab and elranatamab in relapsed or refractory multiple myeloma in the United States.
Lucio N Gordan, Arielle G Bensimon, Fan Mu, Nina Kim, Bingcao Wu, Dee Lin

J Med Econ· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world patient profile and step-up dosing process of early initiators of teclistamab for multiple myeloma in US hospitals: An analysis using the Premier Healthcare Database.
Carlyn Rose Tan, Eric Chinaeke, Nina Kim, Dee Lin, Laura Hester

J Manag Care Spec Pharm· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden of illness among patients with relapsed or refractory multiple myeloma, and eligible for B-cell maturation antigen-targeted therapies.
Smith Giri, Dee Lin, Ruth Wangia Dixon, Nina Kim, Jessica Fowler

Future Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Safety and Health Care Resource Utilization of Teclistamab Under an Outpatient Model for Step-Up Dosing Administration.
Tyler B Sandahl, Scott A Soefje, Rafael Fonseca, Sikander Ailawadhi, Ricardo Parrondo, Dee Lin, Yi Lin

JCO Oncol Pract· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Evidence Evaluating Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma: A Systematic Literature Review.
Benjamin Derman, Carlyn Tan, Ian Steinfield, Florence R Wilson, Dee Lin

Cancers (Basel)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of cytokine release syndrome and indicators of severity in retrospective databases among patients receiving immunotherapy.
Scott F Huntington, Dee Lin, Marie-Hélène Lafeuille, Philippe Thompson-Leduc, Aditi Shah

Pharmacol Res Perspect· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient, Care Partner, and Physician Voices in Treatment Decision-Making for Multiple Myeloma.
Lisa Dwyer Orr, Dee Lin, Bingcao Wu, Thomas W LeBlanc, Beth Faiman, Erika Kline

Patient Prefer Adherence· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Perspectives on Social and Identity Factors Affecting Multiple Myeloma Care: Barriers and Opportunities.
Natalia Neparidze, Amandeep Godara, Dee Lin, Hoa H Le, Karen Fixler

Healthcare (Basel)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Social Needs and Identity Experiences on the Burden of Illness in Patients with Multiple Myeloma: A Mixed-Methods Study.
Natalia Neparidze, Amandeep Godara, Dee Lin, Hoa H Le, Karen Fixler

Healthcare (Basel)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Panel Interview of ONcology practices with Emergent Experience of teclistamab in the Real world: the TecPIONEER Study.
Benjamin A Derman, Meaghan Roach, Dee Lin, Bingcao Wu, Richard Murphy

Curr Med Res Opin· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient perspectives on BCMA-targeted therapies for multiple myeloma: a survey conducted in a patient advocacy group.
Jay R Hydren, Dee Lin, Nathan W Sweeney, Bingcao Wu, Nina Kim

Front Health Serv· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Cross-Sectional Study of Patient Out-of-Pocket Costs for Antipsychotics Among Medicaid Beneficiaries with Schizophrenia.
Dee Lin, Dominic Pilon, Laura Morrison, Aditi Shah, Marie-Hélène Lafeuille

Drugs Real World Outcomes· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Budget impact of introducing once-every-6-months paliperidone palmitate in US health care plans.
Hilary Phelps, Dee Lin, Alex Keenan, Aditya Raju, Danmeng Huang

J Manag Care Spec Pharm· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Projecting the economic outcomes of switching patients with schizophrenia from oral atypical antipsychotics to once-monthly, once-every-3-months, and once-every-6-months paliperidone palmitate.
Laura Morrison, Dee Lin, Carmela Benson, Isabelle Ghelerter, Maude Vermette-Laforme

J Manag Care Spec Pharm· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of clinical outcomes in patients with schizophrenia following different long-acting injectable event-driven initiation strategies.
Christoph U Correll, Carmela Benson, Bruno Emond, Charmi Patel, Marie-Hélène Lafeuille, Dee Lin

Schizophrenia (Heidelb)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unemployment, Homelessness, and Other Societal Outcomes Among US Veterans With Schizophrenia Relapse: A Retrospective Cohort Study.
Dee Lin, Hyunchung Kim, Keiko Wada, Maya Aboumrad, Ethan Powell

Prim Care Companion CNS Disord· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unemployment, homelessness, and other societal outcomes in patients with schizophrenia: a real-world retrospective cohort study of the United States Veterans Health Administration database : Societal burden of schizophrenia among US veterans.
Dee Lin, Hyunchung Kim, Keiko Wada, Maya Aboumrad, Ethan Powell

BMC Psychiatry· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-psychiatrist discordance and drivers of prescribing long-acting injectable antipsychotics for schizophrenia management in the real-world: a point-in-time survey.
Alexander Keenan, Dee Lin, Jason Shepherd, Hollie Bailey, Carmela Benson

BMC Psychiatry· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence, incidence and economic burden of schizophrenia among Medicaid beneficiaries.
Dominic Pilon, Charmi Patel, Marie-Hélène Lafeuille, Maryia Zhdanava, Dee Lin

Curr Med Res Opin· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Schizophrenia population health management: perspectives of and lessons learned from population health decision makers.
Meaghan Roach, Dee Lin, Marlon Graf, Priti Pednekar, Jacquelyn W Chou

J Manag Care Spec Pharm· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations Between Relapses and Psychosocial Outcomes in Patients With Schizophrenia in Real-World Settings in the United States.
Dee Lin, Kruti Joshi, Alexander Keenan, Jason Shepherd, Hollie Bailey

Front Psychiatry· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Real-World Evidence of the Clinical and Economic Impact of Long-Acting Injectable Versus Oral Antipsychotics Among Patients with Schizophrenia in the United States: A Systematic Review and Meta-Analysis.
Dee Lin, Philippe Thompson-Leduc, Isabelle Ghelerter, Ha Nguyen, Marie-Hélène Lafeuille

CNS Drugs· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic burden in Medicaid beneficiaries with recently relapsed schizophrenia or with uncontrolled symptoms of schizophrenia not adherent to antipsychotics.
Dominic Pilon, Charmi Patel, Marie-Hélène Lafeuille, Maryia Zhdanava, Dee Lin

J Manag Care Spec Pharm· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and Healthcare Burden of Patients with Schizophrenia Treated in a US Integrated Healthcare System.
Rohan Mahabaleshwarkar, Dee Lin, Kruti Joshi, Jesse Fishman, Todd Blair

J Ment Health Policy Econ· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Evidence of the Clinical and Economic Impact of Long-Acting Injectable Versus Oral Antipsychotics Among Patients with Schizophrenia in the United States: A Systematic Review and Meta-Analysis.
Dee Lin, Philippe Thompson-Leduc, Isabelle Ghelerter, Ha Nguyen, Marie-Hélène Lafeuille

CNS Drugs· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis